Systematic review of ease-control studies: Oral contraceptives show no effect on melanoma risk

Public Health Reviews

Volumn 25, Issue 3-4, 1997, Pages 309-315

  Pfahlberg, Annette ^a   Hassan, Karola ^a   Wille, Lutz ^a   Lausen, Berthold ^b   Gefeller, Olaf ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Melanoma; Oral contraceptives; Recta analysis; Skin cancer

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; HUMAN; MEDICAL INFORMATION; MELANOMA; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN CARCINOGENESIS; BIOLOGY; CANCER; CASE CONTROL STUDIES; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CORRELATIONAL STUDY; DERMATOLOGICAL EFFECTS; DISEASES; FAMILY PLANNING; FEMALE; LITERATURE REVIEW; META ANALYSIS; METHODOLOGY; NEOPLASM; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; RISK; SKIN TUMOR; STATISTICAL MODEL; STATISTICAL STUDIES; STUDIES;

BIOLOGY; CANCER; CASE CONTROL STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CORRELATION STUDIES; DERMATOLOGICAL EFFECTS; DISEASES; FAMILY PLANNING; LITERATURE REVIEW; NEOPLASMS; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; RESEARCH METHODOLOGY; RISK FACTORS; STATISTICAL STUDIES; STUDIES;

CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MELANOMA; MODELS, STATISTICAL; ODDS RATIO; SKIN NEOPLASMS;

EID: 0031283507     PISSN: 03010422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fisher RI, Neifeld JP, Lippman ME, Oestrogen receptors in human malignant melanoma. Lancet 1976; 2: 337-339.
2. Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. BrJ Cancer 1977; 36: 804-809.
3. Adam SA, Sheaves JK, Wright NH, Mosser G, Harris RW, Vessey MP. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981; 44: 45-50.
4. Bain C, Hennekens CH, Speizer FE, Rosner B, Willett W, Belanger C. Oral contraceptive use and malignant melanoma. J Natl Cancer Inst 1982; 68: 537-539.
5. Lew RA, Sober AJ, Cook N, Marvell R, Fitzpatrick TB. Sun exposure habits in patients with cutaneous melanoma: a case-control study. J Dermatol Surg Oncol 1983; 9: 981-986.
6. Holly EA, Weiss NS, Liff JM. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 1983; 70: 827-831.
7. Helmrich SP, Rosenberg L, Kaufmann DW, Miller DR, Schottenfeld D, Stolley PD, Shapiro S. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst 1984; 73:617-620.
8. Holman CDJ, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50: 673-680.
9. Beral V, Evans S, Shaw H, Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 1984; 50: 681-685.
10. Green A, Bain C. Hormonal factors and melanoma in women. Med J Aust 1985; 142: 446-448.
11. Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer 1985; 52: 901-907.
12. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 1988; 42: 821-824.
13. Augustsson A, Stierner U, Rosdahl I, Suurküla M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Dermatol Venereol 1990; 71: 518-424.
14. Zanetti R, Franceschi S, Rosso S, Bidoli E, Colonna S. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol 1990; 19: 522-526.
15. Lê MG, Cabanes PA, Desvignes V, Chanteau MF, Mlika N, Avril MF. Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control 1992; 3: 199-205.
16. Palmer JR, Rosenberg L, Strom BL, Harlap S, Zauber AG, Warshauer ME, Shapiro S. Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 1992; 3: 547-554.
17. Zaridze D, Mukeria A, Duffy SW. Risk factors for skin melanoma in Moscow. Int J Cancer 1992, 52: 159-161.
18. Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 1995; 141: 943-950.
19. Westerdahl J, Olsson H, Masbäck A, Ingvar C, Jonsson N. Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 1996; 73: 1126-1131.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
21. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
22. Mosteller F, Colditz GA. Understanding research synthesis (meta-analysis). Annu Rev Public Health 1996; 17: 1-23.